Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. | Blood | 2021 | 34343258 | PubTator, text mining | PubMed |
| Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation. | JCO Glob Oncol | 2021 | 34343012 | PubTator, text mining | PubMed |
| CBFB-MYH11 Fusion Sequesters RUNX1 in Cytoplasm to Prevent DNMT3A Recruitment to Target Genes in AML. | Front Cell Dev Biol | 2021 | 34336831 | PubTator, text mining | PubMed |
| AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. | Oncogene | 2021 | 34331016 | PubTator, text mining | PubMed |
| MEIS1 and its potential as a cancer therapeutic target (Review). | Int J Mol Med | 2021 | 34318904 | PubTator, text mining | PubMed |
| Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia. | Ann Hematol | 2021 | 34312685 | PubTator, text mining | PubMed |
| Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue. | Mol Cancer Res | 2021 | 34312290 | PubTator, text mining | PubMed |
| Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. | Front Oncol | 2021 | 34307137 | PubTator, text mining | PubMed |
| Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways. | Int J Mol Sci | 2021 | 34299194 | PubTator, text mining | PubMed |
| Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation. | Int J Mol Sci | 2021 | 34299191 | PubTator, text mining | PubMed |
| Gene Transcription as a Therapeutic Target in Leukemia. | Int J Mol Sci | 2021 | 34298959 | PubTator, text mining | PubMed |
| DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model. | Cancers (Basel) | 2021 | 34298798 | PubTator, text mining | PubMed |
| Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms. | PLoS One | 2021 | 34297770 | PubTator, text mining | PubMed |
| Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity. | Front Pharmacol | 2021 | 34295243 | PubTator, text mining | PubMed |
| Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques. | PLoS One | 2021 | 34288963 | PubTator, text mining | PubMed |
| A Case of Acute Eosinophilic Leukemia with a Novel PHF6 Mutation. | Case Rep Hematol | 2021 | 34285820 | PubTator, text mining | PubMed |
| Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting. | Cancer Manag Res | 2021 | 34285581 | PubTator, text mining | PubMed |
| Trisomy 21-associated increases in chromosomal instability are unmasked by comparing isogenic trisomic/disomic leukocytes from people with mosaic Down syndrome. | PLoS One | 2021 | 34283872 | PubTator, text mining | PubMed |
| Differential Regulation of Lacto-/Neolacto- Glycosphingolipid Biosynthesis Pathway Reveals Transcription Factors as Potential Candidates in Triple-Negative Breast Cancer. | Cancers (Basel) | 2021 | 34283051 | PubTator, text mining | PubMed |
| Functional annotation of noncoding mutations in cancer. | Life Sci Alliance | 2021 | 34282050 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=56